Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India

Infectious Diseases and Therapy

Volumn 5, Issue 3, 2016, Pages 379-387

  Vijayakumar, Saranya ^a   Gopi, Radha ^a   Gunasekaran, Priya ^a   Bharathy, Manjurekar ^b   Walia, Kamini ^c   Anandan, Shalini ^a   Veeraraghavan, Balaji ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b VIT UNIVERSITY   (India)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Insertion sequence; Metallo beta lactamases; Oxacillinases

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TETRACYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BLAGES GENE; BLANDM GENE; BLAOXA 23 GENE; BLAOXA 51 GENE; BLAPER GENE; BLASHV GENE; BLATEM GENE; BLAVEB GENE; BLAVIM GENE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONTROLLED STUDY; DISK DIFFUSION; GENE MAPPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRACHEAL ASPIRATION PROCEDURE;

EID: 85006105982     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-016-0125-y     Document Type: Article

References (24)

1. Abbott Iain, Cerqueira GM, Bhuiyan S, Peleg AY. Carbapenem resistance in Acinetobacter. Laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther. 2013;11(4):395–409.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–51.
3. Roca I, Espinal P, Vila-Farrés X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 2012;3:Article 148.
4. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826–36.
5. Kim UJ, Kim HK, An JH, Cho SK, Park K-H, Jang H-C. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med J. 2014;50(2):37.
6. Turton JF, Ward E, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006;258:72–7.
7. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974–6.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty second informational supplement M100–S22. Wayne: CLSI; 2014.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty second informational supplement M100–S22. Wayne: CLSI; 2015.
10. Dortet L, Poirel L, Errera C, Nordmann P. Carbacineto NP test for rapid detection of carbapenemase-producers in Acinetobacter spp. J Clin Microbiol. 2014. doi:10.1128/JCM.00594-14.
11. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important b-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:490–5.
12. Lascols C, Hackel M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother. 2011;9:1992–7.
13. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing betalactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151–61.
14. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119–23.
15. Woodford Neil, Ellington Matthew J, Coelho Juliana M, Turton Jane F, Elaina Ward M, Brown Susan, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27:351–3.
16. Segal H, Garny S, Elisha BG. Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett. 2005;243:425–9.
17. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.
18. Kamolvit W, Sidjabat HE, Paterson DL. Molecular epidemiology and mechanisms of carbapenem resistance of Acinetobacter spp. in Asia and Oceania. Microb Drug Resist. 2015;21(4):424–34.
19. Saranathan R, Vasanth V, Vasanth T, Shabareesh PRV, Shashikala P, Devi CS, et al. Emergence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii strains of CC 103B and CC 92B clonal complexes harboring OXA-type carbapenemases and metallo-β-lactamases in Southern India. Microbiol Immunol. 2015;59(5):277–84.
20. Amudhan SM, Sekar U, Arunagiri K, Sekar B. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol. 2011;29(3):269–74.
21. Evans BA, Amyes SGB. OXA β-lactamases. Clin Microbiol Rev. 2014;27(2):241.
22. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35–40.
23. Evans BA, Hamouda A, Amyes SGB. The rise of carbapenem-resistant Acinetobacter baumannii. Curr Pharm Des. 2013;19:223–38.
24. Héritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(8):3198–202.